Literature DB >> 20012868

Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample.

Maiza Ritomy Ide1, Miguel A Gonzalez-Gay, Kelly Cristina Yano, Marcelo Jun Imai, Mario Chueire de Andrade, Javier Llorca.   

Abstract

The main objective of this study is to compare Spanish and Brazilian self-reported health-related functional capacity in patients with rheumatoid arthritis (RA). 197 patients diagnosed with RA were studied in Spain (n = 127) and Brazil (n = 70). Pain (Visual analog scale) and functional capacity (Health Assessment Questionnaire/HAQ) were assessed. Patients were questioned about regular exercise practice. Comparisons between groups were performed with Chi-square tests and Student t test. Pearson's correlation coefficient and linear regression models were used to analyze the associations. Brazilian patients were younger (p = 0.013), had worse levels of pain (p = 0.001) and a trend to experience worse functional capacity (p = 0.057) than Spanish ones. Spanish RA patients had higher body mass index (BMI) (p = 0.019) and longer disease duration (p = 0.001). Also, a higher percentage of subjects with RA from the Spanish cohort had been elected to take early retirement when compared with Brazilian patients (p = 0.010). Spanish RA patients had received more drugs than Brazilians (oral corticosteroids p = 0.010, Leflunomide p = 0.023, Methotrexate p = 0.072, non-steroidal anti-inflammatory drugs p = 0.064, biologic therapies p = 0.001). The functional capacity (HAQ) was correlated with age (p = 0.001), disease duration (p = 0.001), age at diagnosis (p = 0.001), pain (p = 0.001) and BMI (p = 0.001) in Spanish patients. In Brazilian, these correlations were only found with disease duration (p = 0.004) and pain (p = 0.001). In conclusion, our data suggest a better management of RA in Spanish when compared with Brazilians. Even with less pain and functional capacity, they receive more drug treatment and a higher percentage of them are retired early.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012868     DOI: 10.1007/s00296-009-1282-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  35 in total

1.  JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations.

Authors:  D M Phillips
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

2.  Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.

Authors:  M A Gonzalez-Gay; M T Garcia-Unzueta; A Berja; T R Vazquez-Rodriguez; C Gonzalez-Juanatey; J M de Matias; J Martin; P H Dessein; J Llorca
Journal:  Ann Rheum Dis       Date:  2008-11       Impact factor: 19.103

Review 3.  Population aging today: demands, challenges and innovations.

Authors:  Renato Veras
Journal:  Rev Saude Publica       Date:  2009-04-17       Impact factor: 2.106

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  The prevalence of rheumatoid arthritis in the general population of Spain.

Authors:  L Carmona; V Villaverde; C Hernández-García; J Ballina; R Gabriel; A Laffon
Journal:  Rheumatology (Oxford)       Date:  2002-01       Impact factor: 7.580

6.  Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.

Authors:  K L Hyrich; K D Watson; A J Silman; D P M Symmons
Journal:  Rheumatology (Oxford)       Date:  2006-05-16       Impact factor: 7.580

7.  Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association.

Authors:  William L Haskell; I-Min Lee; Russell R Pate; Kenneth E Powell; Steven N Blair; Barry A Franklin; Caroline A Macera; Gregory W Heath; Paul D Thompson; Adrian Bauman
Journal:  Med Sci Sports Exerc       Date:  2007-08       Impact factor: 5.411

8.  Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis.

Authors:  Mary-Ann Fitzcharles; Deborah DaCosta; Mark A Ware; Yoram Shir
Journal:  J Pain       Date:  2008-12-13       Impact factor: 5.820

9.  Short-term effect of anti-TNF-alpha therapy on nitric oxide production in patients with severe rheumatoid arthritis.

Authors:  M A Gonzalez-Gay; M T Garcia-Unzueta; A Berja; T R Vazquez-Rodriguez; J A Miranda-Filloy; C Gonzalez-Juanatey; J M de Matias; J Martin; P H Dessein; J Llorca
Journal:  Clin Exp Rheumatol       Date:  2009 May-Jun       Impact factor: 4.473

10.  A cross-cultural study of pain intensity in Egyptian and Dutch women with rheumatoid arthritis.

Authors:  Alexander P J Vlaar; Peter M ten Klooster; Erik Taal; Rasha E Gheith; Ayman K El-Garf; Johannes J Rasker; Mart A F J van de Laar
Journal:  J Pain       Date:  2007-06-13       Impact factor: 5.820

View more
  2 in total

1.  Low-level laser therapy in different stages of rheumatoid arthritis: a histological study.

Authors:  Ana Carolina Araruna Alves; Paulo de Tarso Camillo de Carvalho; Marcio Parente; Murilo Xavier; Lucio Frigo; Flávio Aimbire; Ernesto Cesar Pinto Leal Junior; Regiane Albertini
Journal:  Lasers Med Sci       Date:  2012-04-27       Impact factor: 3.161

Review 2.  Effects of obesity on function and quality of life in chronic pain conditions.

Authors:  Laura-Isabel Arranz; Magda Rafecas; Cayetano Alegre
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.